Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Perioperative management of drug-eluting stents: the Achilles heel of bridging.

Brilakis ES, Banerjee S.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1113-4. doi: 10.1002/ccd.25243. No abstract available.

PMID:
24255030
2.

A case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors.

Singh M, Bolla VH, Berg R.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1108-12. doi: 10.1002/ccd.24845. Epub 2013 Apr 29.

PMID:
23378243
3.

Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.

Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, Kelly KC, Rangan BV, Banerjee S, Brilakis ES.

EuroIntervention. 2013 Jun 22;9(2):204-11. doi: 10.4244/EIJV9I2A35.

4.

Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies.

Warshauer J, Patel VG, Christopoulos G, Kotsia AP, Banerjee S, Brilakis ES.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):25-31. doi: 10.1002/ccd.25507. Epub 2014 May 6. Review.

PMID:
24740634
5.

Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.

Bozzani A, Ferlini M, Rossini R, Musumeci G, Arici V, Bramucci E, Setacci C.

J Cardiovasc Surg (Torino). 2015 Aug;56(4):681-3. Epub 2014 Jul 10. No abstract available.

PMID:
25008060
6.

The complexity of stenting in bifurcation coronary lesions.

Kornowski R.

JACC Cardiovasc Interv. 2013 Jul;6(7):696-7. doi: 10.1016/j.jcin.2013.04.005. No abstract available.

7.

Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.

Ben Morrison T, Horst BM, Brown MJ, Bell MR, Daniels PR.

Catheter Cardiovasc Interv. 2012 Mar 1;79(4):575-82.

PMID:
22448399
8.

Late stent thrombosis: can it be prevented?

Mauri L, Galper BZ.

JACC Cardiovasc Interv. 2014 Oct;7(10):1103-4. doi: 10.1016/j.jcin.2014.06.008. No abstract available.

9.

The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.

Helft G.

Arch Cardiovasc Dis. 2015 Oct;108(10):469-71. doi: 10.1016/j.acvd.2015.09.001. Epub 2015 Oct 1. No abstract available.

PMID:
26432274
10.

A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.

Biondi-Zoccai GG, Valgimigli M, Sheiban I, Margheri M, Marzocchi A, Prati F, Vischi M, Lettieri C, Violini R, Sardella G, Stabile A, Clementi F, Romeo F, Colombo A, Sangiorgi G.

J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):957-62. doi: 10.2459/JCM.0b013e3282ffd3a6.

PMID:
18695440
11.

Less may be more: insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry.

Klein AJ, Brilakis ES.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):417-9. doi: 10.1002/ccd.24571. No abstract available.

PMID:
22933349
12.

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL.

Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x.

PMID:
22954234
13.

Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.

Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.

Catheter Cardiovasc Interv. 2013 May;81(6):E237-44. doi: 10.1002/ccd.24513. Epub 2012 Nov 14.

PMID:
22707383
14.

Recurrent very late drug-eluting stent thrombosis.

Duchini M, Fournier S, Iglesias JF, Roguelov C, Muller O, Eeckhout E.

Int J Cardiol. 2013 Oct 9;168(4):e111-2. doi: 10.1016/j.ijcard.2013.07.251. Epub 2013 Aug 2. No abstract available.

PMID:
23988303
15.

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.

Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):395-405. doi: 10.1002/ccd.23337. Epub 2012 Jan 10.

PMID:
22109961
16.

Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation.

Kammerer T, Beiras-Fernandez A, Rehm M, Stangl M, Guba M, Kupatt-Jeremias C, Weis F.

BMC Cardiovasc Disord. 2014 Sep 1;14:112. doi: 10.1186/1471-2261-14-112.

17.

Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery.

Rassi AN, Blackstone E, Militello MA, Theodos G, Cavender MA, Sun Z, Ellis SG, Cho L.

Am J Cardiol. 2012 Aug 15;110(4):485-90. doi: 10.1016/j.amjcard.2012.04.016. Epub 2012 May 15.

PMID:
22591672
18.

Cilostazol--a forgotten antiplatelet agent, but does it even matter?

Lavie CJ, DiNicolantonio JJ.

JACC Cardiovasc Interv. 2013 Sep;6(9):943-4. doi: 10.1016/j.jcin.2013.06.006. No abstract available.

19.

Should all stent patients have prolonged dual antiplatelet therapy?

Kirtane AJ, King SB 3rd.

JACC Cardiovasc Interv. 2015 May;8(6):873-5. doi: 10.1016/j.jcin.2015.04.001. No abstract available.

20.

Complementary effects of sirolimus-eluting stents and glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention in diabetic patients: one-year follow up of a single-centre registry.

de Araujo Goncalves P, Seabra-Gomes R, Teles R, Almeida M, Aguiar C, Raposo L, Ferreira J, Pereira Machado F.

Heart. 2006 Aug;92(8):1155-6. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk